Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 401–500 of 1,001
The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice
Wang, J., Jia, Y., Li, G., Wang, B., Zhou, T., Zhu, L., Chen, T., & Chen, Y. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy005 · Cited by 62
“Among the inflammatory animal models of depression, peripheral administration of LPS is an experimental approach that causes the activation of microglia and proinflammatory cytokines (TNF-α, IL-1β, and IL-6) (Andre et al., 2008; O’Connor et al., 2009).”
BackgroundResultInfluentialGabbay, V., Liebes, L., Katz, Y., Liu, S., Mendoza, S., Babb, J. S., Klein, R. G., & Gonen, O. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.015 · Cited by 64
“…induced depressive-like symptoms, and that systemic inhibition of IDO activity blocked the development of depressive-like symptoms in mice (i.e. duration of immobility in forced-swim and tail suspension tests) following an immunological challenge with lipopolysaccharide (O'Connor et al., 2009).”
BackgroundMethodInfluentialLiao, L., Zhang, X. D., Li, J., Zhang, Z. W., Yang, C., Rao, C., Zhou, C., Zeng, L., Zhao, L., Fang, L., et al. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.036 · Cited by 67
Yoshida, T., Yoshimura, M., & Amakura, Y. (2018) · Molecules · doi:10.3390/molecules23030552 · Cited by 63
“Peripherally injected LPS is reported to induce a depressive-like abnormal behavior through induction of microglial immune responses in the brain of mice [80].”
BackgroundAmani, M., Shokouhi, G., & Salari, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5137-8 · Cited by 64
Jeon, S.-A., Lee, E., Hwang, I., Han, B., Park, S., Son, S., Yang, J., Hong, S., Kim, C. H., Son, J., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx065 · Cited by 62
“Emerging evidence has suggested that IDO acts as a central mediator of cytokine-induced depression (O’Connor et al., 2009; Walker et al., 2014; Miller and Raison, 2016) and that systemic LPS administration induces a manifest upregulation of IDO in the hippocampal region (Andre et al.”
BackgroundMethodInfluentialTaniguti, E. H., Ferreira, Y. S., Stupp, I. J. V., Fraga-Junior, E. B., Mendonça, C. B., Rossi, F. L., Ynoue, H. N., Doneda, D. L., Lopes, L., Lima, E., et al. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.02.034 · Cited by 62
Shi, Z., Ren, H., Huang, Z., Peng, Y., He, B., Yao, X., Yuan, T.-F., & Su, H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0212-9 · Cited by 62
Suleymanova, E. M. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.107869 · Cited by 60
Neuronal Mitochondrial Dysfunction and Bioenergetic Failure in Inflammation-Associated Depression
Casaril, A. M., Dantzer, R., & Orth, C. B. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.725547 · Cited by 71
Self-citationCircadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions
Fowler, S., Hoedt, E. C., Talley, N. J., Keely, S., & Burns, G. L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.825246 · Cited by 66
Schrepf, A., Lutgendorf, S. K., & Pyter, L. M. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.04.010 · Cited by 66
Kurosawa, N., Shimizu, K., & Seki, K. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4084-x · Cited by 61
Liu, C., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130204031 · Cited by 61
Cheng, D., Qin, Z., Zheng, Y. F., Xie, J.-Y., Liang, S., Zhang, J., Feng, Y., & Zhang, Z. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.022 · Cited by 61
Dugan, A. M., Parrott, J. M., Redus, L., Hensler, J. G., & O’Connor, J. C. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv089 · Cited by 60
“We and others have found that neuroinflammation upregulates the kynurenine pathway of tryptophan metabolism and that inflammation-induced depressive-like behaviors in mice are dependent on this pathway (O’Connor et al., 2009; Walker et al, 2013).”
BackgroundSelf-citationJangra, A., Kwatra, M., Singh, T., Pant, R., Kushwah, P., Sharma, Y., Saroha, B., Datusalia, A. K., & Bezbaruah, B. K. (2016) · Inflammation · doi:10.1007/s10753-016-0332-4 · Cited by 69
The Footprint of Kynurenine Pathway in Cardiovascular Diseases
Ala, M., & Eftekhar, S. P. (2022) · International Journal of Tryptophan Research · doi:10.1177/11786469221096643 · Cited by 68
Immune and behavioral consequences of microglial reactivity in the aged brain
Wynne, A. M., Henry, C. J., & Godbout, J. P. (2009) · Integrative and Comparative Biology · doi:10.1093/icb/icp009 · Cited by 59
“This same report indicated that, in the absence of immune stimulation, peripheral administration of L-KYN mimicked the acute depressive-like effects of LPS in adult mice (O’Connor et al. 2008).”
BackgroundPredictable chronic mild stress promotes recovery from LPS-induced depression
Dang, R., Guo, Y., Zhang, K., Jiang, P., & Zhao, M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0463-2 · Cited by 66
Microglial activation contributes to depressive-like behavior in dopamine D3 receptor knockout mice
Wang, J., Lai, S., Li, G., Zhou, T., Wang, B., Cao, F., Chen, T., Zhang, X., & Chen, Y. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.10.016 · Cited by 64
Park, H. J., Kim, S. A., Kang, W. S., & Kim, J. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041899 · Cited by 59
“Increased levels of proinflammatory cytokines can affect Ido-1/2 and tryptophan 2,3dioxygenase-2 (Tdo-2) activity, promoting the metabolism of TRP to KYN [19,31,32].”
BackgroundKynurenine metabolism and inflammation-induced depressed mood: a human experimental study
Kruse, J. L., Cho, J. H.-J., Olmstead, R., Hwang, L., Faull, K., Eisenberger, N. I., & Irwin, M. R. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104371 · Cited by 59
Watne, L. O., Pollmann, C. T., Neerland, B. E., Quist‐Paulsen, E., Halaas, N. B., Idland, A., Hassel, B., Henjum, K., Knapskog, A., Frihagen, F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163472 · Cited by 60
“pharmacological or genetic inhibition of IDO prevents depressive- and anxiety-like behaviors as well as cognitive deficits typically seen alongside acute inflammation (23-25).”
Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways
Shen, B., Zhang, H., Zhu, Z., Ling, Z., Zeng, F., Wang, Y., & Wang, J. (2023) · Molecules · doi:10.3390/molecules28041873 · Cited by 65
Moretti, M., Budni, J., Freitas, A. E., Neis, V. B., Ribeiro, C. M., Balen, G. O., Rieger, D. K., Leal, R. B., & Rodrigues, A. L. S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.006 · Cited by 58
Elgarf, A. A., Aboul‐Fotouh, S., Abd-Alkhalek, H. A., El‐Tabbal, M., Hassan, A. N. E.-D., Kassim, S. K., Hammouda, G. A., Farrag, K. A. E.-R., & Abdel-Tawab, A. M. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.09.014 · Cited by 61
“Moreover, O'Connor et al. (2008) reported that blockade of IDO activation either indirectly with minocycline, or directly with IDO antagonist prevented LPS-induced development of depressive-like behavior, but not sickness behavior.”
InfluentialToward an Anti-Inflammatory Strategy for Depression
Hayley, S. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00019 · Cited by 56
Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice
Dostal, C. R., Carson Sulzer, M., Kelley, K. W., Freund, G. G., & McCusker, R. H. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2017.02.002 · Cited by 57
“Independent of this, Ido1-FL and Ido1-v2 are inducible in vivo by inflammatory signals such as LPS (Brooks et al., 2016a; O'Connor et al., 2009b) and Ido1-FL induction in the mouse brain by mycobacterium infection is IFNg-dependent (O'Connor et al., 2009a).”
BackgroundSelf-citationMicroRNAs as critical biomarkers of major depressive disorder: a comprehensive perspective
Ortega, M. A., Alvarez-Mon, M. A., García-Montero, C., Fraile-Martinez, O., Lahera, G., Monserrat, J., Muñoz-Merida, L., Mora, F., Rodríguez-Jiménez, R., Fernandez-Rojo, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111659 · Cited by 57
“the activation of the indoleamine 2,3-dioxygenase (IDO) enzyme [154].”
BackgroundHersey, M., Samaranayake, S., Berger, S. N., Tavakoli, N. S., Mena, S., Nijhout, H. F., Reed, M. C., Best, J. A., Blakely, R., Reagan, L. P., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2618-20.2021 · Cited by 59
Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression
Ely, B. A., Nguyen, T. N. B., Tobe, R. H., Walker, A., & Gabbay, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.678709 · Cited by 60
“In mice, peripheral inhibition of IDO has been shown to block transcription of IDO in the brain and prevent the development of depression- and anhedonia-like behaviors following immunological stimulation (218, 219).”
BackgroundAn integrated cytokine and kynurenine network as the basis of neuroimmune communication
Stone, T. W., Clanchy, F. I. L., Huang, Y., Chiang, N., Darlington, L. G., & Williams, R. O. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1002004 · Cited by 61
Daniele, S., Da Pozzo, E., Zappelli, E., & Martini, C. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.006 · Cited by 56
“LPS administration can induce depression-like behaviours in animals [52-54].”
BackgroundZhou, W., Dantzer, R., Budac, D. P., Walker, A. K., Mao‐Ying, Q., Lee, A. W., Heijnen, C. J., & Kavelaars, A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.013 · Cited by 58
Self-citationJiang, X., Chen, L., Shen, L., Chen, Z., Xu, L., Zhang, J., & Yu, X. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.029 · Cited by 59
Allen, A. P., Naughton, M., Dowling, J. L., Walsh, A. E. L., O'Shea, R., Shorten, G., Scott, L. V., McLoughlin, D. M., Cryan, J. F., Clarke, G. A., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.02.011 · Cited by 61
McNutt, M. D., Liu, S., Manatunga, A., Royster, E. B., Raison, C. L., Woolwine, B. J., Demetrashvili, M. F., Miller, A. H., & Musselman, D. L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.330 · Cited by 56
Li, Y., Eskelund, A., Zhou, H., Budac, D., Sánchez, C., & Gulinello, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160715150 · Cited by 54
Paeonol attenuates lipopolysaccharide-induced depressive-like behavior in mice
Tao, W., Wang, H., Su, Q., Chen, Y., Xue, W., Xia, B., Duan, J., & Chen, G. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.033 · Cited by 58
“endotoxin lipopolysaccharide (LPS) (O’Connor et al., 2009) or TNFα (Krishnadas and Cavanagh, 2012) induce depressive-like beha-”
BackgroundGawali, N. B., Bulani, V. D., Chowdhury, A. A., Deshpande, P. S., Nagmoti, D. M., & Juvekar, A. R. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.07.004 · Cited by 60
Jiang, X., Yan, Q., Liu, F., Jing, C., Ding, L., Zhang, L., & Pang, C. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.064 · Cited by 56
Zang, X., Zheng, X., Hou, Y., Hu, M., Wang, H., Bao, X., Zhou, F., Wang, G., & Hao, H. (2018) · The FASEB Journal · doi:10.1096/fj.201700853r · Cited by 59
Developmental Signatures of Microbiota-Derived Metabolites in the Mouse Brain
Swann, J. R., Spitzer, S. O., & Heijtz, R. D. (2020) · Metabolites · doi:10.3390/metabo10050172 · Cited by 61
“Through this mechanism, LPS has been shown to induce depressive-like behaviors in mice [32].”
BackgroundGyles, T. M., Nestler, E. J., & Parise, E. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01625-0 · Cited by 57
Ma, M., Ren, Q., Zhang, J.-C., & Hashimoto, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.31 · Cited by 54
Byrne, M. L., Whittle, S., & Allen, N. B. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000311 · Cited by 52
“This activates expression of indoleamine 2,3-dioxygenase (IDO) in the brain (33), which reduces tryptophan levels and, in turn, activates production of kynurenine (24).”
BackgroundZhou, Y., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., Chen, L., & Ning, Y. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.001 · Cited by 57
Cathomas, F., Guetter, K., Seifritz, E., Klaus, F., & Kaiser, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89335-9 · Cited by 59
Immunotherapy for depression: Recent insights and future targets
Bai, Y., Cai, Y., Chang, D., Li, D., Huo, X., & Zhu, T. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108624 · Cited by 58
Comai, S., Cavalletto, L., Chemello, L., Bernardinello, E., Ragazzi, E., Costa, C., & Bertazzo, A. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.10.009 · Cited by 55
Wu, Y. H., Fu, Y., Rao, C., Li, W., Liang, Z., Zhou, C., Shen, P., Cheng, P., Zeng, L., Zhu, D., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.04.032 · Cited by 55
IDO/Kynurenine; novel insight for treatment of inflammatory diseases
Lashgari, N., Roudsari, N. M., Shayan, M., Shahraki, F. N., Hosseini, Y., Momtaz, S., & Abdolghaffari, A. H. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156206 · Cited by 58
IFN-γ differentially modulates memory-related processes under basal and chronic stressor conditions
Litteljohn, D., Nelson, E., & Hayley, S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00391 · Cited by 52
“Moreover, variation in the IFN-γ gene was recently reported to modify both depression risk (in the context of IFN-α treatment; Oxenkrug et al., 2011) and antidepressant medication effectiveness (Myint et al., 2013).”
BackgroundEskelund, A., Li, Y., Budac, D. P., Müller, H. K., Gulinello, M., Sanchez, C., & Wegener, G. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14043 · Cited by 52
Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review
de Oliveira, M. R., Chenet, A. L., Duarte, A. R., Scaini, G., & Quevedo, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0680-6 · Cited by 57
Yao, W., Zhang, J.-C., Dong, C., Zhuang, C., Hirota, S., Inanaga, K., & Hashimoto, K. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.012 · Cited by 57
“Alternatively, when bacterial endotoxin lipopolysaccharide (LPS) is administered to rodents, depression-like behaviors are induced after the induction of inflammation (Dantzer et al., 2008; O'Connor et al., 2009).”
BackgroundMurakami, Y., Ishibashi, T., Tomita, E., Imamura, Y., Tashiro, T., Watcharanurak, K., Nishikawa, M., Takahashi, Y., Takakura, Y., Mitani, S., et al. (2016) · Scientific Reports · doi:10.1038/srep29920 · Cited by 52
Neuroimmune endocrine effects of antidepressants
Carvalho, L. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16409 · Cited by 53
Biesmans, S., Matthews, L. J. R., Bouwknecht, J. A., Haes, P. D., Hellings, N., Meert, T. F., Nuydens, R., & Donck, L. V. (2016) · BioMed Research International · doi:10.1155/2016/9085273 · Cited by 58
Jiang, X., Xu, L., Tang, L., Liu, F., Chen, Z., Zhang, J., Chen, L., Pang, C., & Yu, X. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1037-9 · Cited by 54
“Brain levels of KYN and TRP were determined as previously described [14].”
Sahu, P., Mudgal, J., Arora, D. S., Kinra, M., Mallik, S. B., Rao, C. M., Pai, K. S. R., & Nampoothiri, M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5166-y · Cited by 54
“Increased oxidative stress leads to neuroinflammation and neuronal cell death which ultimately results in sickness type behavior and depression (O’connor et al. 2009; Ren et al. 2018).”
BackgroundWang, T., Xu, H. Y., Dong, R., Wu, S., Guo, Y., & Wang, D. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112567 · Cited by 53
Lin, P., Li, D., Shi, Y., Li, Q., Guo, X., Dong, K., Chen, Q., Lou, X., Li, Z., Li, P., et al. (2021) · Nutrients · doi:10.3390/nu15071752 · Cited by 58
“induce depression-like symptoms [35,36,49]; in agreement, animal studies have revealed that administration of LPS induces Ido expression in different brain regions, resulting in depressive-like behaviors [50,51].”
ResultRicardi, C., Barachini, S., Consoli, G., Marazziti, D., Polini, B., & Chiellini, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063203 · Cited by 56
Choubey, P., Kwatra, M., Pandey, S. N., Kumar, D., Dwivedi, D. K., Rajput, P., Mishra, A., Lahkar, M., & Jangra, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5105-3 · Cited by 53
Xue, T., Yan, M., Wang, L., Zhou, Y., Wang, Z., Xia, T., Liu, X., Pan, R., & Chang, Q. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041460 · Cited by 51
“Furthermore, a rate-limiting enzyme in the KYN pathway, indoleamine 2, 3-dioxygenase (IDO), has been implicated as a critical molecular mediator of inflammation-induced depressive-like behavior [9].”
BackgroundResultDong, C., Zhang, J.-C., Yao, W., Ren, Q., Yang, C., Ma, M., Han, M., Saito, R., & Hashimoto, K. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.02.005 · Cited by 53
The effects of fisetin on lipopolysaccharide-induced depressive-like behavior in mice
Yu, X., Jiang, X., Zhang, X., Chen, Z., Xu, L., Chen, L., Wang, G., & Pan, J. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9839-5 · Cited by 52
Zhang, F., Fu, Y.-Y., Zhou, X.-Y., Pan, W.-H., Shi, Y., Wang, M., Zhang, X., Qi, D.-S., Li, L., Ma, K., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.06.001 · Cited by 44
Li, M., Shao, H., Zhang, X., & Qin, B. (2016) · Inflammation · doi:10.1007/s10753-016-0402-7 · Cited by 50
Gong, W., Zhang, S., Zong, Y., Halim, M., Ren, Z., Wang, Y., Ma, Y., Li, B., Ma, L., Zhou, G., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.05.009 · Cited by 52
Wu, W., Peng, G., Yang, F., Zhang, Y., Mu, Z., & Han, X. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10405 · Cited by 57
Antidepressant and Antiaging Effects of Açaí (Euterpe oleracea Mart.) in Mice
Monteiro, J. R. S., Arrifano, G. D. P., Queiroz, A. I. D. G., Mello, B. S. F., Custódio, C. S., Macêdo, D. S., Hamoy, M., Paraense, R. S. D. O., Bittencourt, L. O., Lima, R. R., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3614960 · Cited by 55
“The latter tests are gold-standard methods for evaluating the depressive-like phenotype in rodents, especially to demonstrate the presence of despair-like and anhedonia behaviors [44, 49].”
BackgroundThe role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder
Öztürk, M., Sapmaz, Ş. Y., Kandemır, H., Taneli, F., & Aydemır, Ö. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13739 · Cited by 55
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
Ritsner, M. S. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5 · Cited by 51
The dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression
Rubio-Casillas, A., & Fernández-Guasti, A. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0066 · Cited by 49
“…catalyst to degrade tryptophan into kynurenine (KYN; Myint and Kim, 2003; Schiepers et al., 2005), whereas IDO inhibition is sufficient to prevent the development of depressivelike behavior induced by acute or chronic inflammation (O’Connor et al., 2009; Dobos et al., 2012; Gibney et al., 2014).”
BackgroundHoyo-Becerra, C., Huebener, A., Trippler, M., Lutterbeck, M., Liu, Z. J., Truebner, K., Bajanowski, T., Gerken, G., Hermann, D. M., & Schlaak, J. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083149 · Cited by 49
Kelley, K. W., O’Connor, J. C., Lawson, M. A., Dantzer, R., Rodriguez-Zas, S. L., & McCusker, R. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.02.003 · Cited by 49
Self-citationSens, J. P., Schneider, E. C., Mauch, J., Schaffstein, A., Mohamed, S., Fasoli, K., Saurine, J., Britzolaki, A., Thelen, C., & Pitychoutis, P. M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.12.016 · Cited by 52
“This dose of LPS was chosen for its ability to reliably induce the acute sickness response and subsequent depressive-like behaviours in male mice across the time-points examined here (Frenois et al., 2007; O'Connor et al., 2009; Walker et al., 2013).”
BackgroundSoczynska, J. K., Kennedy, S. H., Alsuwaidan, M., Mansur, R. B., Li, M., McAndrews, M. P., Brietzke, E., Woldeyohannes, H. O., Taylor, V. H., & McIntyre, R. S. (2017) · Bipolar Disorders · doi:10.1111/bdi.12496 · Cited by 49
TRPV4 inhibitor HC067047 produces antidepressant-like effect in LPS-induced depression mouse model
Li, W., Xu, Y., Liu, Z., Shi, M., Zhang, Y., Deng, Y., Zhong, X., Chen, L., He, J., Zeng, J., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108834 · Cited by 53
Basic Aspects of the Immunology of Neuroinflammation
Wohleb, E. S., & Godbout, J. P. (2013) · Modern trends in psychiatry · doi:10.1159/000343964 · Cited by 60
Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model
Wirthgen, E., Tuchscherer, M., Otten, W., Domańska, G., Wollenhaupt, K., Tuchscherer, A., & Kanitz, E. (2013) · Innate Immunity · doi:10.1177/1753425913481252 · Cited by 53
“The depletion of Trp by IDO induction leads to suppression of intracellular pathogens and T-cell proliferation,(4,5) and is associated with the development of depressive-like behavior in mice.(6,7) An increased activity of IDO was also measured in a number of immunologic and neurologic disorders.”
BackgroundMaganin, A. G. M., de Souza, G. R., Fonseca, M. M., Lopes, A. H., Guimarães, R. M., Dagostin, A., Cecílio, N. T., Mendes, A. S., Gonçalves, W. A., Silva, C. E. A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153805 · Cited by 50
“For instance, disturbances in KYNPATH have been implicated in several human diseases, such as depression, schizophrenia, and Alzheimer’s and Huntington’s diseases (6, 7).”
BackgroundSelf-citationLiu, X., Luo, L., Bin-bin, L., Li, J., Geng, D., Liu, Q., & Yi, L. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.03.001 · Cited by 50
“In contrast, blockade of IDO activation with the IDO antagonist 1-methyltryptophan attenuated the depression-like behavior (O’Connor et al., 2009).”
BackgroundMillett, C. E., Phillips, B. E., & Saunders, E. F. H. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.12.008 · Cited by 51
Mudgal, J., Nampoothiri, M., Mallik, S. B., Kinra, M., Hall, S., Grant, G. D., Anoopkumar‐Dukie, S., Rao, C. M., & Arora, D. S. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00638-w · Cited by 52
Ryan, K. M., Allers, K. A., McLoughlin, D. M., & Harkin, A. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.10.005 · Cited by 49
The Role of Inflammation in the Pathophysiology of Depression and Suicidal Behavior
Serafini, G., Costanza, A., Aguglia, A., Amerio, A., Trabucco, A., Escelsior, A., Sher, L., & Amore, M. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.09.001 · Cited by 56
Prophylactic (R,S)-ketamine selectively protects against inflammatory stressors
Mastrodonato, A., Cohensedgh, O., LaGamma, C. T., McGowan, J. C., Hunsberger, H. C., & Denny, C. A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112238 · Cited by 48
Inflammatory pathophysiological mechanisms implicated in postpartum depression
Zhu, J., Jin, J., & Tang, J. Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.955672 · Cited by 54
“The IDO antagonist 1methyltryptophan (1-MT) has been reported to prevent depressive-like behaviors in many animal experiments (O’Connor et al., 2009; Souza et al., 2017).”
BackgroundPan, Y., Lin, W., Wang, W., Qi, X., Wang, D., & Tang, M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.031 · Cited by 45
Ten years of Nature Reviews Neuroscience: insights from the highly cited
Luo, L., Rodríguez, E., Jerbi, K., Lachaux, J.-P., Martinerie, J. M., Corbetta, M., Shulman, G. L., Piomelli, D., Turrigiano, G. G., Nelson, S. B., et al. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2912 · Cited by 50
Self-citationMahmoud, M. E., Ihara, F., Fereig, R. M., Nishimura, M., & Nishikawa, Y. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.11.005 · Cited by 50
“up-regulation by inflammatory agents [43, 44].”
BackgroundResultInfluentialLi, Z.-Q., Yan, Z.-Y., Lan, F.-J., Dong, Y.-Q., & Xiong, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.085 · Cited by 48
Yeh, C., Hsieh, L.-P., Lin, M.-C., Wei, T.-S., Lin, H., Chang, C., & Hsing, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191070 · Cited by 49
“Modulate the IDO activation can reduced LPS-induced depressive like behavior or anhedonia [46].”
BackgroundImmune mechanisms of stress susceptibility and resilience: Lessons from animal models
Tsyglakova, M., McDaniel, D. K., & Hodes, G. E. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100771 · Cited by 49
Naeem, K., Kury, L. T. A., Nasar, F., Alattar, A., Alshaman, R., Shah, F. A., Khan, A., & Li, S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s294413 · Cited by 47
“The exact mechanism of LPS-induced neurodegeneration is not known, but multiple studies suggest the involvement of Toll-like receptor (TLR)-4, whose activation leads to elevated levels of inflammatory mediators.(15) The cross-talk of inflammation and oxidative stress significantly perturbs certain antioxidant proteins…”
BackgroundRetractedCalcaterra, V., Rossi, V., Magenes, V. C., Baldassarre, P., Grazi, R., Loiodice, M., Fabiano, V., & Zuccotti, G. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1368283 · Cited by 46
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.